Sell 8/5/2024Upgraded
Precision BioSciences, Inc. (DTIL) was upgraded to D from E+ on 8/5/2024 due to a significant increase in the efficiency index, growth index and valuation index. EBIT increased 676.69% from -$4.19M to $24.15M, net income increased 281.33% from $8.59M to $32.75M, and total revenue increased 183.77% from $17.58M to $49.9M.

Sell 3/14/2023Downgrade
Precision BioSciences, Inc. (DTIL) was downgraded to E+ from D- on 3/14/2023 due to a decline in the solvency index, total return index and volatility index. Debt to equity increased from 0.29 to 0.4, and the quick ratio declined from 3.48 to 3.19.

Sell 2/23/2023Upgraded
Precision BioSciences, Inc. (DTIL) was upgraded to D- from E+ on 2/23/2023 due to an increase in the total return index.

Sell 2/8/2023Downgrade
Precision BioSciences, Inc. (DTIL) was downgraded to E+ from D- on 2/8/2023 due to a decline in the growth index and solvency index. Debt to equity increased from 0.23 to 0.29, and the quick ratio declined from 4.35 to 3.48.

Sell 8/9/2022Downgrade
Precision BioSciences, Inc. (DTIL) was downgraded to D- from D on 8/9/2022 due to a major decline in the growth index, total return index and volatility index. EBIT declined 8.25% from -$27.35M to -$29.6M.

Sell 5/16/2022Upgraded
Precision BioSciences, Inc. (DTIL) was upgraded to D from E+ on 5/16/2022 due to an increase in the valuation index.

Sell 5/13/2022Downgrade
Precision BioSciences, Inc. (DTIL) was downgraded to E+ from D on 5/13/2022 due to a decline in the solvency index, volatility index and total return index. Debt to equity increased from 0.05 to 0.06.

Sell 5/4/2022Upgraded
Precision BioSciences, Inc. (DTIL) was upgraded to D from E+ on 05/04/2022.

Sell 5/1/2022Downgrade
Precision BioSciences, Inc. (DTIL) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index and volatility index.

Sell 4/21/2022Upgraded
Precision BioSciences, Inc. (DTIL) was upgraded to D from E+ on 04/21/2022.

Sell 4/20/2022Downgrade
Precision BioSciences, Inc. (DTIL) was downgraded to E+ from D on 4/20/2022 due to a significant decline in the total return index, growth index and solvency index. EBIT declined 166.42% from -$11.54M to -$30.75M, earnings per share declined from -$0.1891 to -$0.3672, and total revenue declined 73.63% from $24.04M to $6.34M.

Sell 11/9/2021Upgraded
Precision BioSciences, Inc. (DTIL) was upgraded to D from E+ on 11/09/2021.

Sell 11/8/2021Downgrade
Precision BioSciences, Inc. (DTIL) was downgraded to E+ from D on 11/8/2021 due to a decline in the valuation index.

Sell 11/2/2020Upgraded
Precision BioSciences, Inc. (DTIL) was upgraded to D from D- on 11/2/2020 due to an increase in the volatility index and valuation index.

Sell 10/16/2020Downgrade
Precision BioSciences, Inc. (DTIL) was downgraded to D- from D on 10/16/2020 due to a decline in the solvency index, valuation index and volatility index. The quick ratio declined from 6.65 to 3.7.

Sell 5/15/2020Upgraded
Precision BioSciences, Inc. (DTIL) was upgraded to D from D- on 5/15/2020 due to an increase in the growth index and valuation index. Total revenue increased 7.3% from $6.52M to $7M.

Sell 12/2/2019Upgraded
Precision BioSciences, Inc. (DTIL) was upgraded to D- from E on 12/2/2019 due to an increase in the volatility index.

Sell 9/3/2019Upgraded
Precision BioSciences, Inc. (DTIL) was upgraded to E from E- on 9/3/2019 due to a significant increase in the efficiency index, solvency index and valuation index. The quick ratio increased from 1.72 to 14.31, total capital increased 174.98% from $63.27M to $173.98M, and debt to equity declined from 4.84 to 0.

Sell 6/21/2019None
Precision BioSciences, Inc. (DTIL) was downgraded to E- from U on 06/21/2019.